[F21.Specified risk material, referred to and listed in Annex 5 and including at least the brain, spinal cord, eyes and tonsils of bovine animals aged over 12 months, and the vertebral column of bovine animals aged over 30 months, must—
(a)be removed and disposed of in accordance with Annex 5 and with Regulation (EC) No 1069/2009;
(b) not be imported into Great Britain from any country other than a member State.
2.Tissues from animals which have undergone one of the alternative tests listed in Annex 10, which is applied under the conditions provided for in Annex 5, and in relation to which the test results are negative, are not to be regarded as specified risk material.]
3.[F3In parts of Great Britain] with a controlled or undetermined BSE risk, the laceration, after stunning, of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity, or by means of gas injection into the cranial cavity in connection with stunning, shall not be used on bovine, ovine or caprine animals whose meat is intended for human or animal consumption.
4. The data relating to age set out in Annex V may be adjusted. Such adjustments shall be based on the latest proven scientific findings concerning the statistical probability of the occurrence of a TSE in the relevant age groups of [F4Great Britain’s] bovine, ovine and caprine population.
[F55. The appropriate authority may by regulations—
(a)prescribe the age of bovine animals from which the vertebral column is to be treated as specified risk material;
(b)amend the list of specified risk material in Annex 5;
(c)prescribe an alternative test to be listed in point 5 of Chapter C of Annex 10;
(d)provide for exemptions;
(e)prescribe, as respects any country or region with a controlled BSE risk—
(i)the date considered by the appropriate authority to be the date from which effective enforcement of a ban on use of mammalian protein in ruminant feed began, and
(ii)that only animals born before that date must have specified risk material removed and destroyed before being moved into or placed on the market.]]
Textual Amendments
F1Substituted by Regulation (EC) No 1923/2006 of the European Parliament and of the Council of 18 December 2006 amending Regulation (EC) No 999/2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (Text with EEA relevance).
F2Art. 8(1)(2) substituted (31.12.2020) by The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 2(6)(a) (as amended by S.I. 2020/1388, regs. 1(2)(a), 20(2)(d)(i)); 2020 c. 1, Sch. 5 para. 1(1)
F3Words in Art. 8(3) substituted (31.12.2020) by The Transmissible Spongiform Encephalopathies and Animal By-Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/170), regs. 1, 2(6)(b) (as amended by S.I. 2020/1388, regs. 1(2)(a), 20(2)(d)(ii)); 2020 c. 1, Sch. 5 para. 1(1)
F4Words in Art. 8(4) amended (31.12.2020) by S.I. 2019/170, reg. 2(6)(c) (as substituted by The Animals, Aquatic Animal Health, Invasive Alien Species, Plant Propagating Material and Seeds (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1388), regs. 1(2)(a), 20(2)(d)(iii))
F5Art. 8(5) substituted for Art. 8(5)(6) (31.12.2020) by The Animals (Legislative Functions) (EU Exit) Regulations 2019 (S.I. 2019/588), regs. 1, 4(8) (with reg. 12) (as amended by S.I. 2020/1463, regs. 1(2)(a), 6(3)(c)); 2020 c. 1, Sch. 5 para. 1(1)